Healthcare [ 13/13 ] | Drug Manufacturers - Specialty & Generic [ 95/164 ]
NASDAQ | Common Stock
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers.
The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream.
The company serves to hemodialysis clinics.
Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 21, 24 | -0.05 Increased by +75.00% | -0.07 Increased by +28.57% |
| Nov 14, 23 | -0.07 Increased by +82.50% | -0.10 Increased by +30.00% |
| Aug 14, 23 | -0.18 Increased by +67.86% | -0.12 Decreased by -50.00% |
| May 15, 23 | -0.10 Decreased by -11.11% | -0.16 Increased by +37.50% |
| Mar 30, 23 | -0.20 Decreased by -122.22% | -0.39 Increased by +48.72% |
| Nov 14, 22 | -0.40 Increased by +54.55% | -0.48 Increased by +16.67% |
| Aug 15, 22 | -0.56 Increased by +43.43% | -0.81 Increased by +30.86% |
| Apr 8, 22 | -0.09 Increased by +89.77% | -0.99 Increased by +90.91% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 22.09 M Increased by +14.39% | -1.51 M Increased by +45.10% | Decreased by -6.84% Increased by +52.01% |
| Sep 30, 23 | 23.77 M Increased by +27.18% | -1.87 M Increased by +59.93% | Decreased by -7.88% Increased by +68.49% |
| Jun 30, 23 | 18.08 M Decreased by -3.22% | -3.31 M Increased by +39.38% | Decreased by -18.28% Increased by +37.36% |
| Mar 31, 23 | 19.67 M Increased by +28.28% | -2.46 M Increased by +72.49% | Decreased by -12.51% Increased by +78.55% |
| Dec 31, 22 | 19.31 M Increased by +25.97% | -2.75 M Increased by +69.20% | Decreased by -14.26% Increased by +75.55% |
| Sep 30, 22 | 18.69 M Increased by +16.91% | -4.67 M Increased by +38.37% | Decreased by -25.00% Increased by +47.28% |
| Jun 30, 22 | 18.68 M Increased by +23.42% | -5.45 M Increased by +35.10% | Decreased by -29.18% Increased by +47.41% |
| Mar 31, 22 | 15.33 M Decreased by -0.91% | -8.94 M Decreased by -15.34% | Decreased by -58.32% Decreased by -16.40% |